Mechanism of Action The mechanism of Saxenda involves mimicking the bodys natural hormone glucagon-like peptide-1 (GLP-1)
There are also some contraindications, which include a history of pancreatitis or pancreatitis beginning under these treatments, severe gastrointestinal diseases, hypersensitivity and pregnancy, and personal/family history of multiple endocrine neoplasia 2A, 2B, or medullary thyroid cancer [36]
Stay flexible, listen to your body's signals, and partner with your healthcare provider to optimize your approach
Lixisenatide and beinaglutide Lixisenatide and beinaglutide, including EX-BID as discussed earlier, are classified as short-acting GLP-1RAs based on pharmacokinetic characteristics such as clearance half-life and concentration-time distribution
Every brand needs a GLP-1 strategy, said Chloe Depiesse, managing director and GLP-1 consultancy lead at Havas Health